FI944687A0 - Koostumus likinäköisyyden ennaltaehkäisemiseksi ja hoitamiseksi - Google Patents

Koostumus likinäköisyyden ennaltaehkäisemiseksi ja hoitamiseksi

Info

Publication number
FI944687A0
FI944687A0 FI944687A FI944687A FI944687A0 FI 944687 A0 FI944687 A0 FI 944687A0 FI 944687 A FI944687 A FI 944687A FI 944687 A FI944687 A FI 944687A FI 944687 A0 FI944687 A0 FI 944687A0
Authority
FI
Finland
Prior art keywords
myopia
treatment
prophylaxis
composition
effects
Prior art date
Application number
FI944687A
Other languages
English (en)
Swedish (sv)
Other versions
FI944687A (fi
Inventor
Toshiro Shigemitsu
Noriko Watanabe
Original Assignee
Senju Pharma Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Senju Pharma Co filed Critical Senju Pharma Co
Publication of FI944687A0 publication Critical patent/FI944687A0/fi
Publication of FI944687A publication Critical patent/FI944687A/fi

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/436Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a six-membered ring having oxygen as a ring hetero atom, e.g. rapamycin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0048Eye, e.g. artificial tears
FI944687A 1993-10-07 1994-10-06 Koostumus likinäköisyyden ennaltaehkäisemiseksi ja hoitamiseksi FI944687A (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP25138393 1993-10-07
JP1253794 1994-02-04

Publications (2)

Publication Number Publication Date
FI944687A0 true FI944687A0 (fi) 1994-10-06
FI944687A FI944687A (fi) 1995-04-08

Family

ID=26348167

Family Applications (1)

Application Number Title Priority Date Filing Date
FI944687A FI944687A (fi) 1993-10-07 1994-10-06 Koostumus likinäköisyyden ennaltaehkäisemiseksi ja hoitamiseksi

Country Status (18)

Country Link
US (1) US5519030A (fi)
EP (1) EP0647445B1 (fi)
KR (1) KR100193406B1 (fi)
CN (1) CN1108095A (fi)
AT (1) ATE175350T1 (fi)
AU (1) AU677860B2 (fi)
BR (1) BR9404007A (fi)
CA (1) CA2133805A1 (fi)
CZ (1) CZ244994A3 (fi)
DE (1) DE69415757T2 (fi)
ES (1) ES2126039T3 (fi)
FI (1) FI944687A (fi)
HU (1) HUT71112A (fi)
NO (1) NO943749L (fi)
NZ (1) NZ264616A (fi)
PL (1) PL305352A1 (fi)
SK (1) SK121394A3 (fi)
TW (1) TW282471B (fi)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5952338A (en) * 1996-07-05 1999-09-14 Takeda Chemical Industries, Ltd. Agent for prophylaxis and treatment of disturbance of visual function
SE0002211D0 (sv) * 2000-06-13 2000-06-13 Synphora Ab Methods and compositions for prevention of myopia
MD38Z5 (ro) * 2009-02-20 2010-02-28 Татьяна ГИДИРИМСКИЙ Metodă de corecţie a vederii la slab văzători
WO2013022801A1 (en) 2011-08-05 2013-02-14 Forsight Vision4, Inc. Small molecule delivery with implantable therapeutic device
EP2640360A2 (en) 2010-11-19 2013-09-25 Forsight Vision4, Inc. Therapeutic agent formulations for implanted devices
EP2968113B8 (en) 2013-03-14 2020-10-28 Forsight Vision4, Inc. Systems for sustained intraocular delivery of low solubility compounds from a port delivery system implant
US9474756B2 (en) * 2014-08-08 2016-10-25 Forsight Vision4, Inc. Stable and soluble formulations of receptor tyrosine kinase inhibitors, and methods of preparation thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4728509A (en) * 1985-08-19 1988-03-01 Takeda Chemical Industries, Ltd. Aqueous liquid preparation
JPH06110587A (ja) * 1992-09-28 1994-04-22 Omron Corp 自動取引き機の電源制御方法とその装置

Also Published As

Publication number Publication date
TW282471B (fi) 1996-08-01
EP0647445B1 (en) 1999-01-07
CA2133805A1 (en) 1995-04-08
ES2126039T3 (es) 1999-03-16
KR100193406B1 (ko) 1999-06-15
FI944687A (fi) 1995-04-08
PL305352A1 (en) 1995-04-18
ATE175350T1 (de) 1999-01-15
AU7441794A (en) 1995-04-27
HUT71112A (en) 1995-11-28
CZ244994A3 (en) 1995-04-12
EP0647445A1 (en) 1995-04-12
HU9402883D0 (en) 1995-01-30
AU677860B2 (en) 1997-05-08
DE69415757T2 (de) 1999-06-10
NO943749D0 (no) 1994-10-06
US5519030A (en) 1996-05-21
DE69415757D1 (de) 1999-02-18
NZ264616A (en) 1997-06-24
KR950010896A (ko) 1995-05-15
SK121394A3 (en) 1995-07-11
CN1108095A (zh) 1995-09-13
NO943749L (no) 1995-04-10
BR9404007A (pt) 1995-06-13

Similar Documents

Publication Publication Date Title
OA09334A (fr) "Dérivés d'acides aminés".
ATE225770T1 (de) Difluoroprostaglandin-derivate und ihre anwendung
DE69114117T2 (de) Neue Verwendung von Peptidderivat.
CA2029420A1 (en) Pharmaceutical compositions and methods for inhibition of maillard's reaction
AU2868689A (en) Use of 1,4-disubstituted-piperidinyl compounds in the manufacture of a medicament for the treatment of insomnia
GR3005990T3 (fi)
FI944687A0 (fi) Koostumus likinäköisyyden ennaltaehkäisemiseksi ja hoitamiseksi
DE69418744D1 (de) Verwendung von Pregnanderivaten zur Behandlung von Tumoren
CA2065889A1 (en) Increasing the choroidal blood flow
ES2087173T3 (es) Uso de derivados de piridoindol en el tratamiento de enfermedades isquemicas.
ES2073871T3 (es) Tiazolidin-2,4-dionas en el tratamiento de la hipertension.
AU2013888A (en) Uricosuric composition
ATE81465T1 (de) Verwendung von 2-oxo-imidazolidin-derivaten zur behandlung von nierenkrankheiten.
TH17660EX (th) สารผสมสำหรับป้องกันและรักษาสายตาสั้น
TH17660A (th) สารผสมสำหรับป้องกันและรักษาสายตาสั้น
RU94035672A (ru) Композиция для профилактики и лечения близорукости, способ ее получения
ES2037825T3 (es) Uso farmaceutico de tioeteres aromaticos.

Legal Events

Date Code Title Description
FD Application lapsed